1. Home
  2. SLNO vs ATHM Comparison

SLNO vs ATHM Comparison

Compare SLNO & ATHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • ATHM
  • Stock Information
  • Founded
  • SLNO 1999
  • ATHM 2008
  • Country
  • SLNO United States
  • ATHM China
  • Employees
  • SLNO N/A
  • ATHM N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ATHM EDP Services
  • Sector
  • SLNO Health Care
  • ATHM Technology
  • Exchange
  • SLNO Nasdaq
  • ATHM Nasdaq
  • Market Cap
  • SLNO 3.7B
  • ATHM 3.3B
  • IPO Year
  • SLNO 2014
  • ATHM 2013
  • Fundamental
  • Price
  • SLNO $48.65
  • ATHM $23.99
  • Analyst Decision
  • SLNO Strong Buy
  • ATHM Hold
  • Analyst Count
  • SLNO 10
  • ATHM 1
  • Target Price
  • SLNO $110.90
  • ATHM $28.00
  • AVG Volume (30 Days)
  • SLNO 2.3M
  • ATHM 334.8K
  • Earning Date
  • SLNO 11-04-2025
  • ATHM 11-06-2025
  • Dividend Yield
  • SLNO N/A
  • ATHM 10.01%
  • EPS Growth
  • SLNO N/A
  • ATHM N/A
  • EPS
  • SLNO N/A
  • ATHM 1.73
  • Revenue
  • SLNO $98,675,000.00
  • ATHM $951,436,680.00
  • Revenue This Year
  • SLNO N/A
  • ATHM N/A
  • Revenue Next Year
  • SLNO $181.30
  • ATHM $1.33
  • P/E Ratio
  • SLNO N/A
  • ATHM $13.77
  • Revenue Growth
  • SLNO N/A
  • ATHM N/A
  • 52 Week Low
  • SLNO $41.50
  • ATHM $23.39
  • 52 Week High
  • SLNO $90.32
  • ATHM $32.70
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 38.14
  • ATHM 32.68
  • Support Level
  • SLNO $46.82
  • ATHM $24.40
  • Resistance Level
  • SLNO $50.04
  • ATHM $25.22
  • Average True Range (ATR)
  • SLNO 3.65
  • ATHM 0.66
  • MACD
  • SLNO -0.83
  • ATHM -0.03
  • Stochastic Oscillator
  • SLNO 22.23
  • ATHM 19.30

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.

Share on Social Networks: